ロード中...
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations
The development of resistance to previously effective treatments has been a challenge for health care providers and a fear for patients undergoing cancer therapy. This is an unfortunately frequent occurrence for patients undergoing targeted therapy for tumours harboring the activating V600E mutation...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5372601/ https://ncbi.nlm.nih.gov/pubmed/28282860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18030585 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|